EntryPoint Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Sell
90,931
-65,586
-42% -$223K 0.12% 341
2026
Q1
$275K Buy
+156,517
New +$339K 0.08% 505
2025
Q2
Sell
-25,827
Closed -$92.7K 643
2025
Q1
$92.7K Buy
25,827
+13,688
+113% +$55K 0.04% 622
2024
Q4
$38.2K Sell
12,139
-9,190
-43% -$32.8K 0.02% 692
2024
Q3
$60.1K Buy
+21,329
New +$48.8K 0.03% 579

Other funds holding CLOV

EntryPoint Capital's CLOV Position: Q2 2026 in Review

EntryPoint Capital reduced its Clover Health Investments (CLOV) stake by 42% in Q2 2026, selling an estimated $223K and leaving 90,931 shares worth $476K. The position accounts for 0.12% of the portfolio, ranked #341.

EntryPoint Capital first reported a position in CLOV in Q3 2024 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • EntryPoint Capital held 90,931 shares of Clover Health Investments worth $476K as of Q2 2026.
  • EntryPoint Capital sold 65,586 Clover Health Investments shares in Q2 2026, an estimated $223K.
  • Clover Health Investments made up 0.12% of EntryPoint Capital's portfolio in Q2 2026, its #341 holding.
  • EntryPoint Capital first reported a position in Clover Health Investments in Q3 2024 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.